Skip to main content

Apellis Pharmaceuticals expanding product pipeline

Gene therapies treat conditions caused by problems in people's DNA, the building blocks of life. Apellis' second experimental compound could make them more effective.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.